0001209191-17-067619.txt : 20171229
0001209191-17-067619.hdr.sgml : 20171229
20171229125659
ACCESSION NUMBER: 0001209191-17-067619
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171227
FILED AS OF DATE: 20171229
DATE AS OF CHANGE: 20171229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARLETT CHRISTOPHER A
CENTRAL INDEX KEY: 0000897744
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 171280909
MAIL ADDRESS:
STREET 1: 100 WILSHIRE BLVD
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 W. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 675 W. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-12-27
0
0001645460
Cue Biopharma, Inc.
CUE
0000897744
MARLETT CHRISTOPHER A
675 W. KENDALL STREET
CAMBRIDGE
MA
02142
1
0
0
0
Warrants
9.375
2017-12-27
4
A
0
833312
A
2018-06-12
2023-06-12
Common Stock
833312
833312
I
See footnote
The Warrants were issued to MDB Capital Group LLC ("MDB") as partial compensation for its services as underwriter in the Company's initial public offering of common stock pursuant to that certain Underwriting Agreement, dated December 14, 2017, between the Company and MDB as representative of the underwriters.
The record owner of these securities is MDB. The reporting person is the Chief Executive Officer of MDB. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein and inclusion of these securities in the report shall not be an admission of beneficial ownership for purposes of section 16 or any other purposes.
/s/ Christopher Marlett by Mark Busch, attorney-in-fact
2017-12-29